case_images: PMC11180837_01
case_images: Representation of different locations of the tumors of all patients. (A, E, I, M, Q, U) Axial view of the tumors in 18F-OC PET (black arrow). (B, F, J, N, R, V) Axial view of the tumors in CT. (C, G, K, O, S, W) Fusion image. (D, H, L, P, T, X) Maximum-intensity projection (MIP) image of the patients (black arrow).
case_images: fendo-15-1400751-g001.jpg
case_images: PMC11180837_06_fendo-15-1400751-g001.jpg
case_images: f1
case_images: ALP levels ranging from 366 to 463 U/L (normal range, 30- 120 U/L), FGF-23 at 17.56 pg/ml (normal range, 23.3- 95.4 pg/ml) and total procollagen type 1 amino-terminal propeptide (tP1NP) at 92.37 ng/ml (normal range, 15.1- 58.6 ng/ml). An 18F-OC PET/CT scan disclosed osseous destruction ( Figures 1U-X ) measuring 17.0 x 10.0 mm on the left side of the occipital bone, displaying significantly increased metabolic activity (SUVmax = 13.15, SUVmean = 5.69, MTV = 1.31 cm3).
case_images: PMC11180837_02
case_images: Representation of different locations of the tumors of all patients. (A, E, I, M, Q, U) Axial view of the tumors in 18F-OC PET (black arrow). (B, F, J, N, R, V) Axial view of the tumors in CT. (C, G, K, O, S, W) Fusion image. (D, H, L, P, T, X) Maximum-intensity projection (MIP) image of the patients (black arrow).
case_images: fendo-15-1400751-g001.jpg
case_images: PMC11180837_06_fendo-15-1400751-g001.jpg
case_images: f1
case_images: ALP levels ranging from 366 to 463 U/L (normal range, 30- 120 U/L), FGF-23 at 17.56 pg/ml (normal range, 23.3- 95.4 pg/ml) and total procollagen type 1 amino-terminal propeptide (tP1NP) at 92.37 ng/ml (normal range, 15.1- 58.6 ng/ml). An 18F-OC PET/CT scan disclosed osseous destruction ( Figures 1U-X ) measuring 17.0 x 10.0 mm on the left side of the occipital bone, displaying significantly increased metabolic activity (SUVmax = 13.15, SUVmean = 5.69, MTV = 1.31 cm3).
case_images: PMC11180837_03
case_images: Representation of different locations of the tumors of all patients. (A, E, I, M, Q, U) Axial view of the tumors in 18F-OC PET (black arrow). (B, F, J, N, R, V) Axial view of the tumors in CT. (C, G, K, O, S, W) Fusion image. (D, H, L, P, T, X) Maximum-intensity projection (MIP) image of the patients (black arrow).
case_images: fendo-15-1400751-g001.jpg
case_images: PMC11180837_06_fendo-15-1400751-g001.jpg
case_images: f1
case_images: ALP levels ranging from 366 to 463 U/L (normal range, 30- 120 U/L), FGF-23 at 17.56 pg/ml (normal range, 23.3- 95.4 pg/ml) and total procollagen type 1 amino-terminal propeptide (tP1NP) at 92.37 ng/ml (normal range, 15.1- 58.6 ng/ml). An 18F-OC PET/CT scan disclosed osseous destruction ( Figures 1U-X ) measuring 17.0 x 10.0 mm on the left side of the occipital bone, displaying significantly increased metabolic activity (SUVmax = 13.15, SUVmean = 5.69, MTV = 1.31 cm3).
case_images: PMC11180837_04
case_images: Representation of different locations of the tumors of all patients. (A, E, I, M, Q, U) Axial view of the tumors in 18F-OC PET (black arrow). (B, F, J, N, R, V) Axial view of the tumors in CT. (C, G, K, O, S, W) Fusion image. (D, H, L, P, T, X) Maximum-intensity projection (MIP) image of the patients (black arrow).
case_images: fendo-15-1400751-g001.jpg
case_images: PMC11180837_06_fendo-15-1400751-g001.jpg
case_images: f1
case_images: ALP levels ranging from 366 to 463 U/L (normal range, 30- 120 U/L), FGF-23 at 17.56 pg/ml (normal range, 23.3- 95.4 pg/ml) and total procollagen type 1 amino-terminal propeptide (tP1NP) at 92.37 ng/ml (normal range, 15.1- 58.6 ng/ml). An 18F-OC PET/CT scan disclosed osseous destruction ( Figures 1U-X ) measuring 17.0 x 10.0 mm on the left side of the occipital bone, displaying significantly increased metabolic activity (SUVmax = 13.15, SUVmean = 5.69, MTV = 1.31 cm3).
case_images: PMC11180837_05
case_images: Representation of different locations of the tumors of all patients. (A, E, I, M, Q, U) Axial view of the tumors in 18F-OC PET (black arrow). (B, F, J, N, R, V) Axial view of the tumors in CT. (C, G, K, O, S, W) Fusion image. (D, H, L, P, T, X) Maximum-intensity projection (MIP) image of the patients (black arrow).
case_images: fendo-15-1400751-g001.jpg
case_images: PMC11180837_06_fendo-15-1400751-g001.jpg
case_images: f1
case_images: ALP levels ranging from 366 to 463 U/L (normal range, 30- 120 U/L), FGF-23 at 17.56 pg/ml (normal range, 23.3- 95.4 pg/ml) and total procollagen type 1 amino-terminal propeptide (tP1NP) at 92.37 ng/ml (normal range, 15.1- 58.6 ng/ml). An 18F-OC PET/CT scan disclosed osseous destruction ( Figures 1U-X ) measuring 17.0 x 10.0 mm on the left side of the occipital bone, displaying significantly increased metabolic activity (SUVmax = 13.15, SUVmean = 5.69, MTV = 1.31 cm3).
case_images: PMC11180837_06
case_images: Representation of different locations of the tumors of all patients. (A, E, I, M, Q, U) Axial view of the tumors in 18F-OC PET (black arrow). (B, F, J, N, R, V) Axial view of the tumors in CT. (C, G, K, O, S, W) Fusion image. (D, H, L, P, T, X) Maximum-intensity projection (MIP) image of the patients (black arrow).
case_images: fendo-15-1400751-g001.jpg
case_images: PMC11180837_06_fendo-15-1400751-g001.jpg
case_images: f1
case_images: ALP levels ranging from 366 to 463 U/L (normal range, 30- 120 U/L), FGF-23 at 17.56 pg/ml (normal range, 23.3- 95.4 pg/ml) and total procollagen type 1 amino-terminal propeptide (tP1NP) at 92.37 ng/ml (normal range, 15.1- 58.6 ng/ml). An 18F-OC PET/CT scan disclosed osseous destruction ( Figures 1U-X ) measuring 17.0 x 10.0 mm on the left side of the occipital bone, displaying significantly increased metabolic activity (SUVmax = 13.15, SUVmean = 5.69, MTV = 1.31 cm3).